To the full analysis
Nissan Chemical stock: growth
4021.TNissan Chemical reported $1.75B in revenue for fiscal 2026, up 11.2% on the prior year, up 6% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
2.5%
per year from 2007 to 2026, per share 4.2%
Earnings (Annual rate)
6.9%
per year from 2007 to 2026, per share 8.7%
Free cash flow (Annual rate)
7.1%
per year from 2007 to 2026, per share 8.9%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2021 | since 2016 | since 2007 | |
|---|---|---|---|
| Revenue | 6.0% | 4.7% | 2.5% |
| Revenue per share | 7.4% | 6.2% | 4.2% |
| Earnings | 8.2% | 8.3% | 6.9% |
| Earnings per share | 9.7% | 9.9% | 8.7% |
| Free cash flow | 7.8% | 8.0% | 7.1% |
| Free cash flow per share | 9.3% | 9.6% | 8.9% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2007 | $1.09B | $87.62M | $76.59M |
| 2008 | $1.06B | $97.08M | $33.93M |
| 2009 | $1B | $62.94M | $26.78M |
| 2010 | $933.24M | $79.85M | $99.51M |
| 2011 | $965.64M | $81.11M | $100.78M |
| 2012 | $930.38M | $68.72M | $81.94M |
| 2013 | $963.11M | $86.91M | $92.68M |
| 2014 | $1.02B | $104.58M | $92.43M |
| 2015 | $1.07B | $113.96M | $74.42M |
| 2016 | $1.11B | $139.95M | $130.99M |
| 2017 | $1.13B | $150.45M | $122.86M |
| 2018 | $1.21B | $169.97M | $147.27M |
| 2019 | $1.28B | $183.93M | $136.5M |
| 2020 | $1.3B | $192.74M | $164.41M |
| 2021 | $1.31B | $209.58M | $194.66M |
| 2022 | $1.3B | $242.82M | $189.3M |
| 2023 | $1.43B | $257.29M | $101.91M |
| 2024 | $1.42B | $238.16M | $89.48M |
| 2025 | $1.57B | $269.52M | $269.29M |
| 2026 | $1.75B | $311.26M | $283.48M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 13 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 31 Mar 2026
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = ¥159.70)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong, published since 7 Nov 2026 (in the score history since 13 Jun 2025)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.